The Association of Fat and Lean Tissue With Whole Body and Spine Bone Mineral Density Is Modified by HIV Status and Sex in Children and Youth
Overview
Authors
Affiliations
Background: HIV-infected (HIV-pos) male children/youth showed lower bone mineral density at sexual maturity than HIV-uninfected (HIV-neg) females. It is not known whether complications of HIV disease, including abnormal body fat distribution, contribute to lower bone accrual in male HIV-pos adolescents.
Methods: In a cross-sectional study, we evaluated the relationship between body composition (fat and lean mass) and bone mass in HIV-pos and HIV-neg children/youth and determined if it is modified by HIV status and sex. We used generalized estimating equations to simultaneously model the effect of fat/lean mass on multiple bone outcomes, including total body bone mineral density and bone mineral content and spine bone mineral density. We evaluated effect modification by HIV and sex.
Results: The analysis cohort consisted of 143 HIV-neg and 236 HIV-pos, of whom 55% were black non-Hispanic and 53% were male. Ages ranged from 7 to < 25 years. Half of the children/youth were at Tanner stage 1 and 20% at Tanner 5. Fat mass was more strongly positively correlated with bone mass in HIV-neg than HIV-pos children/youth and these relationships were more evident for total body bone than spine outcomes. Within HIV strata, fat mass and bone were more correlated in female than male children/youth. The relationship between lean mass and bone varied by sex, but not by HIV status.
Conclusions: HIV disease diminishes the positive relationship of greater fat mass on bone mass in children/youth. Disruptions in body fat distribution, which are common in HIV disease, may have an impact on bone accretion during pubertal development.
de Castro J, de Lima T, Silva D Int J Environ Res Public Health. 2024; 21(5).
PMID: 38791753 PMC: 11121308. DOI: 10.3390/ijerph21050541.
Dirajlal-Fargo S, Jacobson D, Yu W, Mirza A, Geffner M, McComsey G HIV Med. 2023; 25(2):233-244.
PMID: 37845017 PMC: 10872855. DOI: 10.1111/hiv.13566.
Dirajlal-Fargo S, Jacobson D, Yu W, Mirza A, Geffner M, Jao J Clin Infect Dis. 2022; 75(6):945-952.
PMID: 35090002 PMC: 9522403. DOI: 10.1093/cid/ciac053.
Dirajlal-Fargo S, McComsey G Curr HIV/AIDS Rep. 2021; 18(5):424-435.
PMID: 34652624 PMC: 8574078. DOI: 10.1007/s11904-021-00574-x.
Innes S, Patel K Curr Opin HIV AIDS. 2018; 13(3):187-195.
PMID: 29432231 PMC: 5934760. DOI: 10.1097/COH.0000000000000458.